Form 8-K - Current report:
SEC Accession No. 0001683168-25-001987
Filing Date
2025-03-28
Accepted
2025-03-28 16:30:27
Documents
17
Period of Report
2025-03-27
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT aclarion_8k.htm   iXBRL 8-K 37701
2 CERTIFICATE OF AMENDMENT TO THE AMENDED AND RESTATED CERTIFICATE OF INCORPORATIO aclarion_ex0301.htm EX-3.1 5756
7 GRAPHIC image_005.jpg GRAPHIC 66301
8 GRAPHIC image_006.jpg GRAPHIC 169442
  Complete submission text file 0001683168-25-001987.txt   593602

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE acon-20250327.xsd EX-101.SCH 3787
4 XBRL DEFINITION FILE acon-20250327_def.xml EX-101.DEF 26647
5 XBRL LABEL FILE acon-20250327_lab.xml EX-101.LAB 36764
6 XBRL PRESENTATION FILE acon-20250327_pre.xml EX-101.PRE 25271
19 EXTRACTED XBRL INSTANCE DOCUMENT aclarion_8k_htm.xml XML 5911
Mailing Address 8181 ARISTA PLACE STE 100 BROOMFIELD CO 80021
Business Address 8181 ARISTA PLACE STE 100 BROOMFIELD CO 80021 833 275 2266
Aclarion, Inc. (Filer) CIK: 0001635077 (see all company filings)

EIN.: 473324725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41358 | Film No.: 25786843
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)